IMAGE

Fig. 2

ID
ZDB-IMAGE-240725-2
Source
Figures for de Sena-Tomás et al., 2024
Image
Figure Caption

Fig. 2 SB225002 treatment delays and attenuates neutrophil recruitment to the injured spinal cord impairing regeneration. (A) Scheme depicts the administration of SB225002 in 3 dpf zebrafish larvae, starting one hour before SCI and continuing for the first 6 h post-injury. (B-I) Representative maximal projections reveal neutrophils (green) recruited to the spinal cord (magenta) at 2, 4 and 8 hpi. Scale bar, 30 μm. (J) Quantification displays the number of neutrophils at the injured spinal cord, showing a significant delay and reduction in recruitment in SB225002-treated larvae (n = 18–22, performed as three independent experiments). Two-way ANOVA followed by Tukey’s multiple comparisons test indicates a significant difference between SB225002- and DMSO-treated larvae (asterisks) at 2 (p < 0.0001) and 4 hpi (p = 0.0004) with no significant difference at 8 (p = 0.0865), 24 (p > 0.9999), 48 (p > 0.9990) and 72 hpi (p > 0.9999). Statistically significant differences are also observed within each treatment for DMSO-treated larvae (grey pounds) between 4 and 8 hpi (p = 0.0456), and 8 and 24 hpi (p < 0.0001) and for SB225002-treated larvae (green pounds) between 2 and 4 hpi (p < 0.0001). (K) Quantification shows the percentage of reduction in neutrophil counts at the wound. Two-way ANOVA followed by Sidak’s multiple comparison test indicates a significant idecrease between SB225002- and DMSO-treated larvae at 24 hpi (p = and no significant difference at the peak (p > 0.9999), 8 (p = 0.9268), 48 (p = 0.0845) and 72 hpi (p = 0.9952). (L-M) Representative maximal projections of the spinal cord illustrate the axonal bridge. Scale bar, 30 μm. (N) Quantification of the axonal bridge thickness shows a significant decrease in SB225002-treated injured larvae, analyzed via an unpaired two-tailed t-test (p = 0.0349) (n = 15–18, performed as three independent experiments). (O-P) Representative maximal projections of the spinal cord show the glial bridge. Scale bar, 30 μm. (Q) Quantification reveals a significant decrease in the glial bridge in SB225002-treated injured larvae, analyzed through an unpaired two-tailed t-test (p < 0.0001) (n = 28–32, performed as two independent experiments). (R) Recovery of the swimming capacity expressed as the total swim distance in relationship to the healthy control (n = 29–61, performed as three independent experiments). Two-way ANOVA followed by Tukey’s multiple comparison displays significant difference between injured SB225002- and DMSO-treated larvae (asterisks) at 2 (p = 0.0004) and 3 dpi (p = 0.0449); between injured and uninjured DMSO-treated larvae (grey pound) at 1 (p < 0.0001), 2 (p < 0.0001) and 3 dpi (p = 0.0138); and between injured SB225002- and uninjured DMSO-treated larvae (green pound) at 1 (p < 0.0001), 2 (p < 0.0001), 3 (p < 0.0001) and 5 dpi (p = 0.0278).

Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Brain Behav. Immun.